Surgery Partners, Inc. Stock Plummets to New 52-Week Low at $12.25

Surgery Partners, Inc., a small-cap company in the hospital industry, has reached a new 52-week low of USD 12.25 as of March 3, 2026. This marks a significant decline, with the stock's performance over the past year showing a decrease of 45.77%, contrasting sharply with the S&P 500's gain of 17.36% during the same period. The company's market capitalization stands at USD 2,010 million, and it currently has a price-to-earnings (P/E) ratio of 30.00. Despite its small size, Surgery Partners has faced notable financial challenges, including a net profit loss of USD 13.29 million over the last nine months, reflecting a staggering decline of 74.91%. Additionally, the company's debt-to-equity ratio is reported at 1.46, indicating a higher level of debt relative to equity. With a price-to-book ratio of 1.16 and a return on equity of 6.18%, Surgery Partners continues to navigate a difficult financial landscape, having reported negative results for three consecutive quarters. The stock's 52-week high was recorded at USD 24.64, highlighting the extent of its recent downturn.